In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $29.85 in the prior trading day, Apellis Pharmaceuticals Inc (NASDAQ: APLS) closed at $29.47, down -1.27%. In other words, the price has decreased by -$1.27 from its previous closing price. On the day, 1.53 million shares were traded. APLS stock price reached its highest trading level at $30.41 during the session, while it also had its lowest trading level at $29.28.
Ratios:
Our goal is to gain a better understanding of APLS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.18 and its Current Ratio is at 5.08. In the meantime, Its Debt-to-Equity ratio is 1.80 whereas as Long-Term Debt/Eq ratio is at 1.77.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on May 31, 2024, initiated with a Neutral rating and assigned the stock a target price of $46.
On February 05, 2024, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $68 to $80.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 16 ’24 when Dunlop A. Sinclair sold 37,000 shares for $36.23 per share. The transaction valued at 1,340,597 led to the insider holds 100,000 shares of the business.
Chopas James George sold 192 shares of APLS for $6,952 on Sep 16 ’24. The VP/Chief Accounting Officer now owns 38,141 shares after completing the transaction at $36.21 per share. On Sep 16 ’24, another insider, Chopas James George, who serves as the Officer of the company, bought 192 shares for $36.21 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLS now has a Market Capitalization of 3588443904 and an Enterprise Value of 3694922752. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.71 while its Price-to-Book (P/B) ratio in mrq is 13.57. Its current Enterprise Value per Revenue stands at 5.876 whereas that against EBITDA is -11.869.
Stock Price History:
Over the past 52 weeks, APLS has reached a high of $73.80, while it has fallen to a 52-week low of $29.59. The 50-Day Moving Average of the stock is -20.69%, while the 200-Day Moving Average is calculated to be -40.28%.
Shares Statistics:
The stock has traded on average 1.62M shares per day over the past 3-months and 2335400 shares per day over the last 10 days, according to various share statistics. A total of 119.56M shares are outstanding, with a floating share count of 101.06M. Insiders hold about 17.00% of the company’s shares, while institutions hold 92.99% stake in the company. Shares short for APLS as of 1726185600 were 15284852 with a Short Ratio of 9.45, compared to 1723680000 on 16267681. Therefore, it implies a Short% of Shares Outstanding of 15284852 and a Short% of Float of 17.330000000000002.
